These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7744655)

  • 21. Assessment of fat absorption in normal dogs and in dogs with hyperadrenocorticalism.
    Simpson JW; van den Broek AH
    Res Vet Sci; 1990 Jan; 48(1):38-41. PubMed ID: 2300713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An alternative protocol for the medical management of canine pituitary-dependent hyperadrenocorticism.
    Rijnberk A; Belshaw BE
    Vet Rec; 1988 May; 122(20):486-8. PubMed ID: 3420770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetes mellitus, hyperadrenocorticism, and hypothyroidism in a dog.
    Hess RS; Ward CR
    J Am Anim Hosp Assoc; 1998; 34(3):204-7. PubMed ID: 9590447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of the urine cortisol: creatinine ratio to monitor treatment response in dogs with pituitary-dependent hyperadrenocorticism.
    Guptill L; Scott-Moncrieff JC; Bottoms G; Glickman L; Johnson M; Glickman N; Nelson R; Bertoy E
    J Am Vet Med Assoc; 1997 Apr; 210(8):1158-61. PubMed ID: 9108922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of hyperadrenocorticism in dogs: a survey of internists and dermatologists.
    Behrend EN; Kemppainen RJ; Clark TP; Salman MD; Peterson ME
    J Am Vet Med Assoc; 1999 Oct; 215(7):938-43. PubMed ID: 10511856
    [No Abstract]   [Full Text] [Related]  

  • 26. Successful treatment of occult hyperadrenocorticism with mitotane but not trilostane in a dog.
    Park SM; Kim KB; Song WJ; Youn HY
    Vet Med Sci; 2021 Jul; 7(4):1150-1153. PubMed ID: 33755348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitotane (o,p'-DDD) treatment of 200 dogs with pituitary-dependent hyperadrenocorticism.
    Kintzer PP; Peterson ME
    J Vet Intern Med; 1991; 5(3):182-90. PubMed ID: 1656032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term survival of dogs with adrenal-dependent hyperadrenocorticism: a comparison between mitotane and twice daily trilostane treatment.
    Arenas C; Melián C; Pérez-Alenza MD
    J Vet Intern Med; 2014; 28(2):473-80. PubMed ID: 24495125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic availability of o,p'-DDD in normal dogs, fasted and fed, and in dogs with hyperadrenocorticism.
    Watson AD; Rijnberk A; Moolenaar AJ
    Res Vet Sci; 1987 Sep; 43(2):160-5. PubMed ID: 3685628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intermittent heart block in a lethargic dog.
    Swinney GR; Malik R
    Aust Vet J; 1998 Oct; 76(10):663, 667-8. PubMed ID: 9830564
    [No Abstract]   [Full Text] [Related]  

  • 31. Complications and concurrent disease associated with canine hyperadrenocorticism.
    Nichols R
    Vet Clin North Am Small Anim Pract; 1997 Mar; 27(2):309-20. PubMed ID: 9076910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical treatment of canine hyperadrenocorticoidism with o,p'-DDD.
    Lorenz MD; Scott DW; Pulley LT
    Cornell Vet; 1973 Oct; 63(4):646-65. PubMed ID: 4748884
    [No Abstract]   [Full Text] [Related]  

  • 33. Combined corneal lipid and calcium degeneration in a dog with hyperadrenocorticism: a case report.
    Laus JL; dos Santos C; Talieri IC; Oriá AP; Bechara GH
    Vet Ophthalmol; 2002 Mar; 5(1):61-4. PubMed ID: 11940251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trilostane in dogs.
    Ramsey IK
    Vet Clin North Am Small Anim Pract; 2010 Mar; 40(2):269-83. PubMed ID: 20219488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [O.p. DDD (lysodren) in treatment of adrenal cortex hyperfunction in childhood].
    Keller E; Willgerodt H; Teichmann B; Hoepffner W
    Kinderarztl Prax; 1981 Aug; 49(8):436-41. PubMed ID: 7289414
    [No Abstract]   [Full Text] [Related]  

  • 36. Medical treatment of pituitary-dependent hyperadrenocorticism in dogs: should L-deprenyl (Anipryl) ever be used?
    Peterson ME
    J Vet Intern Med; 1999; 13(4):289-90. PubMed ID: 10449217
    [No Abstract]   [Full Text] [Related]  

  • 37. Hyperfunction of the adrenal cortex: a review.
    Lubberink AA; Rijnberk A; Kinderen PJ der ; Thijssen JH
    Aust Vet J; 1971 Oct; 47(10):504-9. PubMed ID: 4942229
    [No Abstract]   [Full Text] [Related]  

  • 38. Hyperadrenocorticism caused by bilateral adrenocortical neoplasia in dogs: four cases (1983-1988).
    Ford SL; Feldman EC; Nelson RW
    J Am Vet Med Assoc; 1993 Mar; 202(5):789-92. PubMed ID: 8454518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic ophthalmology. Idiopathic endophthalmitis with secondary retinal detachment.
    Wolfer J; Grahn B; Kerr D
    Can Vet J; 1996 Jun; 37(6):377-8. PubMed ID: 8689601
    [No Abstract]   [Full Text] [Related]  

  • 40. Mitotane (o,p'-DDD) treatment in a cat with hyperadrenocorticism.
    Schwedes CS
    J Small Anim Pract; 1997 Nov; 38(11):520-4. PubMed ID: 9403812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.